Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats.

Author information

Affiliations

  • 1. Department of Medicine, University of Virginia Health Sciences Center, Charlottesville, 22908, USA.
      Authors
    • Siragy HM 1
    (1 author)

The Journal of Clinical Investigation, 01 Apr 1996, 97(8):1978-1982
https://doi.org/10.1172/jci118630 PMID: 8621783 PMCID: PMC507268

Free full text in Europe PMC

A comment on this article appears in "The curtain rises on the renin-angiotensin system: AT2 receptors are in the spotlight." J Clin Invest. 1996 Apr 15;97(8):1787.

Abstract 

The renal effects of angiotensin II(AII) are attributed to AT1 receptors. In contrast, the function of renal AT2 receptors in unknown. Using a microdialysis technique, we monitored changes in renal interstitial fluid (RIF) prostaglandin E2 (PGE2) and cyclic guanosine 3', 5'-monophosphate (cGMP) in response to dietary sodium (Na) depletion alone, or Na depletion or normal Na diet combined with the AT1 receptor blocker, Losartan, the AT2 receptor blocker, PD 123319 (PD), or angiotensin II, individually or combined in conscious rats. Na depletion significantly increased PGE2 and cGMP. During Na depletion, Losartan decreased PGE2 and did not change cGMP. In contrast, PD significantly increased PGE2 and decreased cGMP. Combined administration of Losartan and PD decreased PGE2 and cGMP. During normal Na diet, RIF PGE2 and cGMP increased in response to angiotensin II. Neither Losartan nor PD, individually or combined, changed RIF PGE2 or cGMP. Combined administration of angiotensin II and Losartan or PD produced a significant decrease in response of PGE2 and cGMP to angiotensin II, respectively. These data demonstrate that activation of the reninangiotensin system during Na depletion increases renal interstitial PGE2 and cGMP. The AT1 receptor mediates renal production of PGE2. The AT2 receptor mediates cGMP. AT2 blockade potentiates angiotensin-induced PGE2 production at the AT1 receptor.

Free full text 

Logo of jcinvestThe Journal of Clinical Investigation
J Clin Invest. 1996 Apr 15; 97(8): 1978–1982.
PMCID: PMC507268
PMID: 8621783

The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats.

H M Siragy and R M Carey
Author information Copyright and License information Disclaimer

Abstract

The renal effects of angiotensin II(AII) are attributed to AT1 receptors. In contrast, the function of renal AT2 receptors in unknown. Using a microdialysis technique, we monitored changes in renal interstitial fluid (RIF) prostaglandin E2 (PGE2) and cyclic guanosine 3', 5'-monophosphate (cGMP) in response to dietary sodium (Na) depletion alone, or Na depletion or normal Na diet combined with the AT1 receptor blocker, Losartan, the AT2 receptor blocker, PD 123319 (PD), or angiotensin II, individually or combined in conscious rats. Na depletion significantly increased PGE2 and cGMP. During Na depletion, Losartan decreased PGE2 and did not change cGMP. In contrast, PD significantly increased PGE2 and decreased cGMP. Combined administration of Losartan and PD decreased PGE2 and cGMP. During normal Na diet, RIF PGE2 and cGMP increased in response to angiotensin II. Neither Losartan nor PD, individually or combined, changed RIF PGE2 or cGMP. Combined administration of angiotensin II and Losartan or PD produced a significant decrease in response of PGE2 and cGMP to angiotensin II, respectively. These data demonstrate that activation of the reninangiotensin system during Na depletion increases renal interstitial PGE2 and cGMP. The AT1 receptor mediates renal production of PGE2. The AT2 receptor mediates cGMP. AT2 blockade potentiates angiotensin-induced PGE2 production at the AT1 receptor.

Full Text

The Full Text of this article is available as a PDF (156K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Navar LG, Rosivall L. Contribution of the renin-angiotensin system to the control of intrarenal hemodynamics. Kidney Int. 1984 Jun;25(6):857–868. [Abstract] [Google Scholar]
  • Macari D, Bottari S, Whitebread S, De Gasparo M, Levens N. Renal actions of the selective angiotensin AT2 receptor ligands CGP 42112B and PD 123319 in the sodium-depleted rat. Eur J Pharmacol. 1993 Nov 2;249(1):85–93. [Abstract] [Google Scholar]
  • Ernsberger P, Zhou J, Damon TH, Douglas JG. Angiotensin II receptor subtypes in cultured rat renal mesangial cells. Am J Physiol. 1992 Sep;263(3 Pt 2):F411–F416. [Abstract] [Google Scholar]
  • Lo M, Liu KL, Lantelme P, Sassard J. Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats. J Clin Invest. 1995 Mar;95(3):1394–1397. [Europe PMC free article] [Abstract] [Google Scholar]
  • Zhuo J, Song K, Harris PJ, Mendelsohn FA. In vitro autoradiography reveals predominantly AT1 angiotensin II receptors in rat kidney. Ren Physiol Biochem. 1992 Sep-Oct;15(5):231–239. [Abstract] [Google Scholar]
  • Zhuo J, Alcorn D, Harris PJ, Mendelsohn FA. Localization and properties of angiotensin II receptors in rat kidney. Kidney Int Suppl. 1993 Jul;42:S40–S46. [Abstract] [Google Scholar]
  • Siragy HM, Howell NL, Ragsdale NV, Carey RM. Renal interstitial fluid angiotensin. Modulation by anesthesia, epinephrine, sodium depletion, and renin inhibition. Hypertension. 1995 May;25(5):1021–1024. [Abstract] [Google Scholar]
  • Siragy HM, Ibrahim MM, Jaffa AA, Mayfield R, Margolius HS. Rat renal interstitial bradykinin, prostaglandin E2, and cyclic guanosine 3',5'-monophosphate. Effects of altered sodium intake. Hypertension. 1994 Jun;23(6 Pt 2):1068–1070. [Abstract] [Google Scholar]
  • Siragy HM, Jaffa AA, Margolius HS. Stimulation of renal interstitial bradykinin by sodium depletion. Am J Hypertens. 1993 Oct;6(10):863–866. [Abstract] [Google Scholar]
  • Harper JF, Brooker G. Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution. J Cyclic Nucleotide Res. 1975;1(4):207–218. [Abstract] [Google Scholar]
  • Powell WS. Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica. Prostaglandins. 1980 Nov;20(5):947–957. [Abstract] [Google Scholar]
  • Dudley DT, Panek RL, Major TC, Lu GH, Bruns RF, Klinkefus BA, Hodges JC, Weishaar RE. Subclasses of angiotensin II binding sites and their functional significance. Mol Pharmacol. 1990 Sep;38(3):370–377. [Abstract] [Google Scholar]
  • Chevalier RL, Fern RJ, Garmey M, el-Dahr SS, Gomez RA, De Vente J. Localization of cGMP after infusion of ANP or nitroprusside in the maturing rat. Am J Physiol. 1992 Mar;262(3 Pt 2):F417–F424. [Abstract] [Google Scholar]
  • Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 Jun;43(2):109–142. [Abstract] [Google Scholar]
  • Keiser JA, Bjork FA, Hodges JC, Taylor DG., Jr Renal hemodynamic and excretory responses to PD 123319 and losartan, nonpeptide AT1 and AT2 subtype-specific angiotensin II ligands. J Pharmacol Exp Ther. 1992 Sep;262(3):1154–1160. [Abstract] [Google Scholar]
  • Clark KL, Robertson MJ, Drew GM. Role of angiotensin AT1 and AT2 receptors in mediating the renal effects of angiotensin II in the anaesthetized dog. Br J Pharmacol. 1993 May;109(1):148–156. [Europe PMC free article] [Abstract] [Google Scholar]
  • Salvemini D, Seibert K, Masferrer JL, Misko TP, Currie MG, Needleman P. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J Clin Invest. 1994 May;93(5):1940–1947. [Europe PMC free article] [Abstract] [Google Scholar]
  • Wong PY, Terragno DA, Terragno NA, McGiff JC. Dual effects of bradykinin on prostaglandin metabolism: relationship to the dissimilar vascular actions of kinins. Prostaglandins. 1977 Jun;13(6):1113–1125. [Abstract] [Google Scholar]
  • Sonnenburg WK, Beavo JA. Cyclic GMP and regulation of cyclic nucleotide hydrolysis. Adv Pharmacol. 1994;26:87–114. [Abstract] [Google Scholar]
  • Hopkins NK, Gorman RR. Regulation of endothelial cell cyclic nucleotide metabolism by prostacyclin. J Clin Invest. 1981 Feb;67(2):540–546. [Europe PMC free article] [Abstract] [Google Scholar]
  • Lim LK, Hunt NH, Eichner RD, Weidemann MJ. Cyclic AMP and the regulation of prostaglandin production by macrophages. Biochem Biophys Res Commun. 1983 Jul 18;114(1):248–254. [Abstract] [Google Scholar]
  • Johnson MD, Malvin RL. Plasma renin activity during pentobarbital anesthesia and graded hemorrhage in dogs. Am J Physiol. 1975 Oct;229(4):1098–1101. [Abstract] [Google Scholar]
Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

Full text links 

Read article at publisher's site: https://doi.org/10.1172/jci118630

Read article for free, from open access legal sources, via Unpaywall: http://www.jci.org/articles/view/118630/files/pdfUnpaywall

Citations & impact 

Impact metrics

191
Citations
Jump to Citations

Citations of article over time

Article citations

Go to all (191) article citations

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.

Funding 

Funders who supported this work.

NHLBI NIH HHS (3)